Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Axsome Thera
(NQ:
AXSM
)
77.35
+1.42 (+1.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Axsome Thera
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
June 03, 2022
These biotech stocks face some key make-or-break events in June that could have big implication for their futures.
Via
InvestorPlace
Jazz Pharmaceuticals Completes U.S. Divestiture Of Sunosi To Axsome Therapeutics, What's Next?
May 09, 2022
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has completed the divestiture of Sunosi (solriamfetol) in the U.S.
Via
Benzinga
FDA Issues Complete Response Letter (CRL) to Axsome Therapeutics for AXS-07 In Acute Migraine
May 02, 2022
The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Axsome Therapeutics, Inc. (NASDAQ: AXSM) regarding its New Drug Application (NDA) for AXS-07 for the acute...
Via
Benzinga
5 Trending Tickers On Benzinga For May 2, 2022: Activision, SoundHound And More
May 02, 2022
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...
Via
Benzinga
A Preview Of Axsome Therapeutics's Earnings
April 29, 2022
Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Axsome...
Via
Benzinga
Axsome Poised To Receive FDA Rejection For Its Migraine Candidate, Shares Fall
April 25, 2022
Via
Benzinga
92 Biggest Movers From Friday
May 09, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...
Via
Benzinga
Where Axsome Therapeutics Stands With Analysts
May 03, 2022
Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter:
Via
Benzinga
As Expected, FDA Rejects Axsome Therapeutics' Migraine Candidate
May 02, 2022
Via
Benzinga
Recap: Axsome Therapeutics Q1 Earnings
May 02, 2022
Axsome Therapeutics (NASDAQ:AXSM) reported its Q1 earnings results on Monday, May 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For May 2, 2022
May 02, 2022
Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million.
Via
Benzinga
Axsome Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 26, 2022
Axsome Therapeutics (NASDAQ:AXSM) will host a conference call at 08:00 AM ET on May 2, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
60 Biggest Movers From Yesterday
April 26, 2022
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 25, 2022
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 25, 2022
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen...
Via
Benzinga
Why Is Axsome Therapeutics (AXSM) Stock Down Today?
April 25, 2022
Axsome Therapeutics (AXSM) stock is falling hard on Monday following a report about an upcoming decision from the FDA this week.
Via
InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points
April 25, 2022
U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday.
Via
Benzinga
Axsome Therapeutics' Good Fortune Reverses As Its Migraine Drug Hits A Hurdle
April 25, 2022
Last week, Axsome stock soared on its depression drug. This week is a different story.
Via
Investor's Business Daily
Why Axsome Therapeutics Stock Is Falling Today
April 25, 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday after the company reported it was informed by the U.S. Food and Drug Administration (FDA) that...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 25, 2022
Via
Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 19, 2022
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'...
Via
Benzinga
54 Biggest Movers From Yesterday
April 20, 2022
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...
Via
Benzinga
Dow Up Over 400 Points as Wall Street Pores Over Earnings
April 19, 2022
Stocks are pointed higher this afternoon, as Wall Street pores over the latest batch of quarterly reports amid one of the busiest weeks of earnings season.
Via
Talk Markets
Hydrogen Stocks News: Why Are PLUG, FCEL, BE Stocks Up Today?
April 19, 2022
Hydrogen stocks are in the news Tuesday as several companies see their shares head higher today thanks to a massive deal.
Via
InvestorPlace
38 Stocks Moving In Tuesday's Mid-Day Session
April 19, 2022
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...
Via
Benzinga
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
April 19, 2022
Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA.
Via
InvestorPlace
Axsome Therapeutics Stock Rockets As Its First FDA Approval Looks Imminent
April 19, 2022
The company agreed to the FDA's post-marketing requirements for a depression drug.
Via
Investor's Business Daily
Axsome Therapeutics Stock Is Surging: Here's Why
April 19, 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Tuesday after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed...
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More
April 19, 2022
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.